Treatment Pathways
Our Treatment Pathways are based on national guidelines and consensus statements, expert opinions from the Infectious Diseases team (pharmacy and medicine), and microbiology data from the microbiology laboratory.
The recommendations provided in the Antimicrobial Guide are meant to serve as treatment guidelines. They should not replace clinical judgment or Infectious Diseases consultation when indicated. The recommendations may not be appropriate at other settings. We have attempted to verify that all information is correct but because of ongoing research, recommendations may change.
Antimicrobial Stewardship Guidebook
DISCLAIMER: The opinions expressed in this publication reflect those of the authors to the best of their ability. However, the authors make no warranty regarding the contents of the publication. The guidelines described herein are general and may not apply to a specific patient.
Fellowship
The following two-year funded fellowship is available through the The Rhode Island Infectious Diseases (RIID) Research Program at the Veterans Affairs Medical Center (VAMC), Providence, in conjunction with the University of Rhode Island (URI) College of Pharmacy, Kingstown, R.I., and the Warren Albert School of Medicine, Brown University, Providence, R.I.
Publications
Our Antimicrobial Stewardship Program is dedicated to the the treatment, outcomes and prevention of infectious diseases caused by important bacterial pathogens that affect public health. We do this by training and mentoring the next generation of progressive researchers in infectious diseases. We disseminate our findings through educational events, and presentations at local, national, and international meetings. Highlights of our work can be found below.
For a complete listing of Kerry LaPLante publications, visit her Research Gate Publications List.
Books
Antimicrobial Stewardship: Principles and Practice, First Edition - K. LaPlante (Editor), Cheston Cunha (Editor), H. Morrill (Editor), Louis Rice (Editor), Eleftherios Mylonakis (Editor)
In an age where antimicrobial resistance among pathogens grows more prevalent, particularly in the hospital setting, antimicrobial stewardship is an evidence-based, proven measure in the battle against resistance and infection.
Infectious Diseases - Jonathan Cohen, William G Powderly and Steven M. Opal, ISBN: 978-0-7020-6285-8
Drs. Cohen, Powderly and Opal, three of the most-respected names in infectious disease medicine, lead a diverse team of international contributors to bring you the latest knowledge and best practices. Extensively updated, the fourth edition includes brand-new information on advances in diagnosis of infection; Hepatitis C; managing resistant bacterial infections; and many other timely topics.
Infection Prevention and Control in Healthcare, Part I: Facility Planning and Management, An Issue of Infectious Disease Clinics of North America - Keith Kaye and Sorabh Dhar, Elsevier Health Sciences, 2016
Dr. Kaye and Dr. Dhor have assembled top experts to write about facility planning and management in Part I of their two issues devoted to Infection Prevention and Control in Healthcare.
Pharmacotherapy: A Pathophysiologic Approach, Ninth Edition - McGraw-Hill Medical, Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey
The 9th edition of Pharmacotherapy: A Pathophysiologic Approach is the product of the editorial team’s reflection on what are the core pathophysiological and therapeutic elements that students and young practioners need.
Posters & Presentations
Epidemiology and treatment heterogeneity in Acinetobacter baumannii infections - ID Week 2020, October 21st -25th 2020.
Aisling R. Caffrey1-4, Haley Appaneal 1-4, Vrishali Lopes1, Kerry L. LaPlante1-3,5 1 Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States, 2Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States, 3College of Pharmacy, University of Rhode Island, Kingston, RI, United States, 4 School of Public Health, Brown University, Providence, RI, 5Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
Trends in Acinetobacter baumannii antibiotic resistance rates - ID Week 2020, October 21st -25th 2020
Aisling R. Caffrey1-4, Emily O’Neill1,3, Haley Appaneal 1-4, Vrishali Lopes1, Kerry L. LaPlante1-3,5 1 Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States, 2Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States, 3College of Pharmacy, University of Rhode Island, Kingston, RI, United States, 4 School of Public Health, Brown University, Providence, RI, 5Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
Treatment heterogeneity in Pseudomonas aeruginosa pneumonia - ID Week 2020, October 21st -25th 2020
Aisling R. Caffrey1-4, Emily C. Bodo1,2, Vrishali Lopes1, Laura A. Puzniak5, Kerry L. LaPlante1-3,6 1Rhode Island Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States; 2College of Pharmacy, University of Rhode Island, Kingston, RI, United States; 3Center of Innovation in Long-Term Support Services (COIN), Providence Veterans Affairs Medical Center, Providence, RI, United States; 4School of Public Health, Brown University, Providence, RI, 5Merck & Co., Inc., Kenilworth, NJ, USA; 6Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
Anti-platelet therapy significantly reduces inpatient mortality in patients with Staphylococcus aureus bacteremia - ID Week 2020, October 21st -25th 2020
Aisling R. Caffrey1-4, Emily O’Neill1, Vrishali Lopes1, Erlinda Ulloa6, George Sakoulas6, Victor Nizet6, Kerry L. LaPlante1-3,5 1 Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States, 2Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States, 3College of Pharmacy, University of Rhode Island, Kingston, RI, United States, 4 School of Public Health, Brown University, Providence, RI, United States, 5Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI, United States, 6University of California San Diego School of Medicine, La Jolla, CA, United States.
Stenotrophomonas maltophilia infections and approaches to treatment - ID Week 2020, October 21st -25th 2020
Aisling R. Caffrey1-4, Haley Appaneal 1-4,Vrishali Lopes1, Kerry L. LaPlante1-3,5 1 Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States, 2Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States, 3College of Pharmacy, University of Rhode Island, Kingston, RI, United States, 4 School of Public Health, Brown University, Providence, RI, 5Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
Trends in Stenotrophomonas maltophilia antibiotic resistance rates - ID Week, October 21st -25th 2020
Aisling R. Caffrey1-4, Emily O’Neill1,3, Haley Appaneal 1-4,Vrishali Lopes1, Kerry L. LaPlante1-3,5 1 Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States, 2Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States, 3College of Pharmacy, University of Rhode Island, Kingston, RI, United States, 4 School of Public Health, Brown University, Providence, RI, 5Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
News
Dr. Kerry LaPlante Represents Society of Infectious Diseases Pharmacists at Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria - On January 30, 2019, SIDP president Kerry LaPlante spoke to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PAC CARB) urging the council to prioritize promoting the development of new antibiotics and protect existing ones. She also advocated for the inclusion of an infectious diseases pharmacist on the Advisory Council.
About the Program
Antimicrobial resistance is globally recognized as one of the greatest healthcare threats. Our goal is to provide health care professionals with the most accurate and up-to-date prescribing information for currently available antimicrobials, ensuring that each patient is on the right drug, route, dose, and duration based on local antibiotic resistance trends in Rhode Island.
Our Treatment Pathways are based on national guidelines and consensus statements, expert opinions from the Infectious Diseases team (pharmacy and medicine), and microbiology data from the microbiology laboratory.
The recommendations provided in our Antimicrobial Guide are meant to serve as treatment guidelines. They should not replace clinical judgment or Infectious Diseases consultation when indicated. The recommendations may not be appropriate at other settings. We have attempted to verify that all information is correct but because of ongoing research, recommendations may change.
We welcome your thoughts and comments. Please contact Program Director Kerry LaPlante, PharmD FCCP.
Contact
Professor and Department Chair College of Pharmacy, University of Rhode Island, Kingston, RI. Adjunct Professor of Medicine, Brown University, Providence, RI. Director of the Rhode Island Infectious Diseases Research Program (RIID) and Infectious Diseases Pharmacotherapy Specialist, Providence Veterans Medical Center, RI.
Providence VA Medical Center, Building 7/URI College of Pharmacy, 295A
401.874.5560
KerryLaPlante@uri.edu
Laboratory Program Coordinator
401.273.7100 x 2328
Kathryn.Daffinee@va.gov
Associate Director, Center of Innovation, Providence VA Medical Center; Department of Primary Care, Providence VA Medical Center; Associate Professor of Medicine and Health Services, Policy and Practice, Brown University
401.273.7100 x 6267
david.dosa@va.gov
Infectious Diseases Pharmacotherapy Fellow
401.273.7100 x 13512
Jennifer.Liao@va.gov
Data Analyst
401.273.7100 x 2321
Vrishali.Lopes@va.gov
Health Services Investigator
401.273.7100 x 6107
Kevin.Mcconeghy2@va.gov
Director of Clinical Outcomes Research (RIID)
401.273.7100 x 4150
haley.morrill@va.gov
